January 7, 2015

WebMD Health and Walgreens announced the availability of Your Digital Health Advisor, a virtual wellness-coaching program powered by WebMD.

 

January 6, 2015

Gilead Sciences’ Harvoni and Sovaldi drugs will be exclusive to CVS Health’s Standard Commercial, Exchange (Marketplace), Medicare Part D and Medicaid formularies.

January 6, 2015

People with type 1 diabetes who intensively control their blood glucose early in their disease are likely to live longer than those who do not.

January 6, 2015

Rite Aid subsidiary Health Dialog announced Tuesday that it has signed an agreement with Network Health.

January 6, 2015

Debuting at the upcoming European trade shows, including Cosmoprof Bologna in March, is the new skin care line SimySkin made with age-specific and formulations to correct, repair and reverse signs of aging.

January 6, 2015

Walgreens on Tuesday announced that December sales increased 10.2% to $7.9 billion.

 

January 6, 2015

As newly insured Americans begin using their 2015 benefits under the Affordable Care Act, Walgreens will again provide medication assistance to those patients who may have difficulty using their new insurance coverage.

January 5, 2015

Atkins Nutritionals on Monday unveiled Atkins 40, a new low-carb weight-loss program that offers greater flexibility and food variety, making it easier to sustain while creating the foundations for healthier eating over a lifetime.

January 5, 2015

Boca Health Remedies announced the introduction of GermWarrior, a nasal inhaler that combats germs, provides a boost to immune defenses and temporarily relieves cold symptoms.

 

January 5, 2015

About half the country is experiencing high levels of flu activity.

 

January 5, 2015

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a Q&A with Owen Mumford's Travis Shaw, in this multi-page report.

January 5, 2015

The Consumer Healthcare Products Association thanked President Obama for signing the Designer Anabolic Steroid Control Act into law last month.

January 5, 2015

The Council for Responsible Nutrition expressed its support in response to a study, “Effect of Maternal Multiple Micronutrient vs Iron–Folic Acid Supplementation on Infant Mortality and Adverse Birth Outcomes in Rural Bangladesh.”

January 5, 2015

CVS Health is now offering talking prescription labels as well as braille and large print labels through its mail service pharmacy to CVS/caremark members who are blind or visually impaired.

January 5, 2015

Healthy Mama on Monday launched Be Well Rounded!, a dye-free prenatal vitamin and DHA supplement system retailing at $29.99 for a two-month supply.

January 5, 2015

Keryx Biopharmaceuticals last month announced it has begun shipping Auryxia (ferric citrate) tablets to wholesalers in the United States. 

January 5, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the vitamins, minerals and supplements and diet aid categories, highlighting new products that are transforming OTC in this multi-page report.

January 5, 2015

Qualcomm on Monday announced that its subsidiary, Qualcomm Life is collaborating with Walgreens to power device connectivity with Walgreens mobile and web applications and its Balance Rewards for healthy choices program with medical device connectivity and care coordination capabilities.

January 5, 2015

Rite Aid on Friday posted a December sales increase of 4.9% to $2.2 billion.

 

January 5, 2015

January marks the launch of the fourth annual Medication Adherence Team Challenge, an inter-collegiate competition to raise awareness about medication adherence.

January 5, 2015

Shoppers Drug Mart pharmacists in Alberta can now offer flu screenings in store — a first for Canadian pharmacies.

December 30, 2014

Vertex Pharmaceuticals has announced that the Food and Drug Administration approved a supplemental new drug application for the use of Kalydeco (ivacaftor) in people with cystic fibrosis ages 6 years and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator gene.

December 29, 2014

Novo Nordisk last week announced that the Food and Drug Administration approved the company's new drug application for Saxenda, a once-daily glucagon-like peptide-1 receptor agonist used as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults.

December 29, 2014

Genentech last week announced that the Food and Drug Administration approved a supplemental biologics license application for Gazyva to be used in combination with chlorambucil chemotherapy in people with previously untreated chronic lymphocytic leukemia.